Obesity management task force of the European association for the study of obesity
Being able to text a clinician a quick question from my phone has kept me consistent like nothing else managed to
While peptide-based GLP-1 receptor agonists such as Exenatide, Liraglutide, Dulaglutide, and Semaglutide have demonstrated strong efficacy, there remains significant interest in developing next-generation therapies
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk
Subcutaneous refers to the layer of tissue just beneath the skin
Clinical trials such as SURMOUNT-1 have demonstrated average weight loss of 15-21% of body weight over 72 weeks (depending on dose), with much of this effect attributed to reduced caloric intake